Cancer Family
Pancreaticobiliary Neoplasm
CI-CAN-00000309Explore in graph →
Non-malignant1,205 active trials11 approved drugs92 evidence items
- NCIt
- C223357
Loading cancer entity…
Cancer Family
CI-CAN-00000309Explore in graph →
Clinical trials
5,005 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00986661 | A Study to Assess PV-10 Chemoablation of Cancer of the Liver | unknown | Phase 1 | 78 | Provectus Biopharmaceuticals, Inc.INDUSTRY | 1 | Nov 2, 2022 | clinicaltrials |
| NCT05596435 | Early Detection of Pancreatic Cancer | unknown | — | 496 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Oct 27, 2022 | clinicaltrials |
| NCT05262452 | Concurrent FOLFIRINOX Plus High Intensity Focused Ultrasound for Pancreatic Cancer | unknown | N/A | 60 | Seoul National University HospitalOTHER | 1 | Oct 26, 2022 | clinicaltrials |
| NCT02773485 | Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma | unknown | Phase 3 | 155 | Tata Memorial HospitalOTHER_GOV | 1 | Oct 21, 2022 | clinicaltrials |
| NCT05587387 | Change of Treatment Landscape and Survival in Metastatic Pancreatic Cancer After Nal-IRI in Republic of Korea | unknown | — | 250 | Yonsei UniversityOTHER | 1 | Oct 20, 2022 | clinicaltrials |
| NCT05587088 | Evaluation of the Safety and Efficacy of Esperanza Extract (PA001)(PA001) | unknown | Phase 1 / Phase 2 | 82 | Hospital Universitario San IgnacioOTHER | 1 | Oct 19, 2022 | clinicaltrials |
| NCT05350943 | HAIC Combined With Toripalimab and Donafenib for Advanced BTC | unknown | Phase 2 | 70 | Lu Wang, MD, PhDOTHER | 1 | Oct 18, 2022 | clinicaltrials |
| NCT05034783 | [68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients | unknown | Early Phase 1 | 20 | Peking Union Medical College HospitalOTHER | 1 | Oct 14, 2022 | clinicaltrials |
| NCT05580887 | Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients | unknown | — | 35 | Moscow Clinical Scientific CenterOTHER | 1 | Oct 14, 2022 | clinicaltrials |
| NCT05571956 | Establishment of Pancreas Cancer and Cancer-associated Fibroblast Using EUS-guided Biopsy Samples | unknown | N/A | 50 | Ajou University School of MedicineOTHER | 1 | Oct 10, 2022 | clinicaltrials |
| NCT05566093 | EUS-FNI for Nonfunctional Pancreatic Neuroendocrine Tumors | unknown | N/A | 20 | Guangxi Medical UniversityOTHER | 1 | Oct 4, 2022 | clinicaltrials |
| NCT05566743 | A Study Evaluating Maintenance Therapy After First Line Chemotherapy in Metastatic Cancer Pancreas | unknown | Phase 2 | 40 | Menoufia UniversityOTHER | 1 | Oct 4, 2022 | clinicaltrials |
| NCT05554744 | EUS-FNI for MEN1-related Pancreatic Neuroendocrine Tumors | unknown | N/A | 20 | Guangxi Medical UniversityOTHER | 1 | Sep 27, 2022 | clinicaltrials |
| NCT03957135 | Laparoscopic Versus Open Distal Pancreatectomy for Pancreatic Cancer: a Multicenter Randomized Controlled Trial | unknown | N/A | 244 | Seoul National University HospitalOTHER | 1 | Sep 21, 2022 | clinicaltrials |
| NCT04801095 | A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 100 | Wellmarker BioINDUSTRY | 2 | Sep 16, 2022 | clinicaltrials |
| NCT05535647 | Second Line Therapy for Advanced Intrahepatic Cholangiocarcinoma | unknown | Phase 2 | 60 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Sep 10, 2022 | clinicaltrials |
| NCT03487016 | First-line Therapy in Metastatic PDAC(FOOTPATH) | unknown | Phase 2 | 270 | Ludwig-Maximilians - University of MunichOTHER | 1 | Sep 8, 2022 | clinicaltrials |
| NCT04398446 | Effect of Hemp-CBD on Patients With CIPN(Coala-T-CBD) | unknown | Phase 2 | 56 | Main Line HealthOTHER | 1 | Sep 1, 2022 | clinicaltrials |
| NCT04782804 | Adjuvant PD-1 Antibody in Combination With Capecitabine for Patients With ICC at High-Risk of Postoperative Recurrence | unknown | Phase 1 / Phase 2 | 30 | Fudan UniversityOTHER | 1 | Aug 18, 2022 | clinicaltrials |
| NCT04856761 | A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection | unknown | — | 160 | Fudan UniversityOTHER | 1 | Aug 18, 2022 | clinicaltrials |
| NCT03069664 | Palliative Pancreatic Duct Stenting in Patients With Inoperable Pancreatic Cancer | unknown | N/A | 40 | Helsinki University Central HospitalOTHER | 1 | Aug 16, 2022 | clinicaltrials |
| NCT05500027 | sCD8, as a Novel Biomarker for Pancreatic Cancer | unknown | — | 2,000 | Peking Union Medical College HospitalOTHER | 1 | Aug 12, 2022 | clinicaltrials |
| NCT05181605 | Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors | unknown | Phase 2 / Phase 3 | 116 | Instituto de investigación e innovación biomédica de CádizOTHER | 1 | Aug 9, 2022 | clinicaltrials |
| NCT05493878 | ITGA2b and SELP Expression in Cancer Pancreas and Biliary Tract Cancer | unknown | — | 128 | Assiut UniversityOTHER | 0 | Aug 9, 2022 | clinicaltrials |
| NCT05290116 | HAIC Combined With Tislelizumab and Apatinib for Unresectable Intrahepatic Cholangiocarcinoma | unknown | Phase 2 | 17 | Yunfei YuanOTHER | 1 | Aug 5, 2022 | clinicaltrials |
| NCT05489419 | Evaluation of Prehabilitation as a Strategy to Minimize Surgical Risk in Pancreatic Surgery: Efficacy and Determining Factors. | unknown | N/A | 56 | Hospital Clinic of BarcelonaOTHER | 1 | Aug 5, 2022 | clinicaltrials |
| NCT04931381 | Organoid-Guided Chemotherapy for Advanced Pancreatic Cancer | unknown | Phase 3 | 100 | Changhai HospitalOTHER | 1 | Aug 2, 2022 | clinicaltrials |
| NCT04931394 | Organoid-Guided Adjuvant Chemotherapy for Pancreatic Cancer | unknown | Phase 3 | 200 | Changhai HospitalOTHER | 1 | Aug 2, 2022 | clinicaltrials |
| NCT05470738 | PAncreas Borderline and Locally Advanced Snapshot Study(PALASS) | unknown | — | 230 | University Hospital, Clermont-FerrandOTHER | 1 | Jul 22, 2022 | clinicaltrials |
| NCT04110769 | Development of Biomarker for the Evaluation of Response After Neoadjuvant Therapy in Patients With Pancreatic Cancer | unknown | N/A | 10 | Asan Medical CenterOTHER | 1 | Jul 20, 2022 | clinicaltrials |
| NCT04136522 | Usefulness of the Artery First Approach in Pancreatic Cancer Surgery | unknown | N/A | 268 | Asan Medical CenterOTHER | 1 | Jul 20, 2022 | clinicaltrials |
| NCT05463328 | Open Versus Laparoscopic Assisted Pancreaticoduodenectomy | unknown | N/A | 40 | Assiut UniversityOTHER | 0 | Jul 19, 2022 | clinicaltrials |
| NCT04362449 | Comparing the Current Hydration Regimen for the ABC02 Chemotherapy Regimen Versus a Shorter Hydration | unknown | Phase 2 | 30 | Imperial College Healthcare NHS TrustOTHER | 1 | Jul 15, 2022 | clinicaltrials |
| NCT04892329 | A Multi-center Study on the Efficacy and Safety of AI-assisted Navigation System for Biliopancreatic EUS | unknown | N/A | 285 | Renmin Hospital of Wuhan UniversityOTHER | 1 | Jul 5, 2022 | clinicaltrials |
| NCT05438797 | The Safety and Efficacy of Specific TIL-TCM Cells for Advanced Relapse-refractory or Metastatic Pancreatic Cancer | unknown | Early Phase 1 | 3 | Sizhen WangOTHER | 1 | Jun 30, 2022 | clinicaltrials |
| NCT05436704 | Is One Pass Enough for the Diagnosis of the Pancreatic Masses During EUS-FNB?(ONE PASS) | unknown | — | 79 | Istituto Clinico Humanitas Mater DominiOTHER | 1 | Jun 29, 2022 | clinicaltrials |
| NCT03792932 | Laparoscopic vs Open Pancreatectomy for Body and Tail Pancreatic Cancer | unknown | N/A | 306 | Fudan UniversityOTHER | 1 | Jun 22, 2022 | clinicaltrials |
| NCT05369312 | Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients | unknown | Phase 1 | 230 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jun 21, 2022 | clinicaltrials |
| NCT04418739 | Intravenous Human Albumin In Improving Pancreaticoduodenectomy Outcomes | unknown | Phase 2 | 122 | Universiti Kebangsaan Malaysia Medical CentreOTHER | 1 | Jun 16, 2022 | clinicaltrials |
| NCT04637048 | Observational Study on Patients With Hepatobiliary Tumors | unknown | — | 1,000 | Gang Chen, MDOTHER | 1 | Jun 16, 2022 | clinicaltrials |
| NCT04258072 | Vactosertib With Nal-IRI/FL in Metastatic Pancreatic Ductal Adenocarcinoma. | unknown | Phase 1 | 24 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT05418543 | CH-EUS in Diagnosis of Inoperable Bile Duct Tumors | unknown | N/A | 40 | Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian FodorOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT05400681 | Liquid Biopsy for ctDNA in Peritoneal Lavage and Blood in Pancreatic Cancer(LIPAC) | unknown | — | 200 | Sonke DetlefsenOTHER | 1 | Jun 8, 2022 | clinicaltrials |
| NCT05399394 | Induction FOLFIRINOX Followed by Chemoradiation in Locally Advanced Pancreatic Cancer(FOLRT) | unknown | Phase 2 | 50 | Campus Bio-Medico UniversityOTHER | 0 | Jun 1, 2022 | clinicaltrials |
| NCT02839343 | Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer | unknown | Phase 2 | 126 | Alliance for Clinical Trials in OncologyOTHER | 2 | May 24, 2022 | clinicaltrials |
| NCT03770559 | The Therapeutic Evaluation(Both Short-term and Long-term Outcome) of Minimal Invasive Radical Antegrade Modular Pancreatosplenectomy for Left-sided Pancreatic Cancer Patients(MIRROR) | unknown | N/A | 125 | Peking Union Medical College HospitalOTHER | 1 | May 20, 2022 | clinicaltrials |
| NCT03741517 | Biomarker Study of Pancreatic Neuroendocrine Tumours | unknown | — | 40 | Uppsala UniversityOTHER | 1 | May 18, 2022 | clinicaltrials |
| NCT04235556 | Integrated Care Pathway in Oncology (PASSION)(PASSION) | unknown | — | 1,800 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | May 13, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Nov 2, 2022source: clinicaltrials